Hybrid Antibacterials. DNA polymerase:topoisomerase inhibitors

por Zhi, Chengxin, Long, Zheng-yu, Manikowski, Andrzej, Comstock, Jeanne, Xu, Wei-Chu, Brown, Neal C., Tarantino, Paul M., Holm, Karsten A., Dix, Edward J., Wright, George E., Barnes, Marjorie H., Butler, Michelle M., Foster, Kimberly A., LaMarr, William A., Bachand, Benoit, Bethell, Richard, Cadilhac, Caroline, Charron, Sylvie, Lamothe, Serge, Motorina, Irina, Storer, Richard
Publicado em 2006

Novel Quinoline-Based P2–P4 Macrocyclic Derivatives As Pan-Genotypic HCV NS3/4a Protease Inhibitors

por Shah, Unmesh, Jayne, Charles, Chackalamannil, Samuel, Velázquez, Francisco, Guo, Zhuyan, Buevich, Alexei, Howe, John A., Chase, Robert, Soriano, Aileen, Agrawal, Sony, Rudd, Michael T., McCauley, John A., Liverton, Nigel J., Romano, Joseph, Bush, Kimberly, Coleman, Paul J., Grisé-Bard, Christiane, Brochu, Marie-Christine, Charron, Sylvie, Aulakh, Virender, Bachand, Benoit, Beaulieu, Patrick, Zaghdane, Helmi, Bhat, Sathesh, Han, Yongxin, Vacca, Joseph P., Davies, Ian W., Weber, Ann E., Venkatraman, Srikanth
Publicado em 2014